Mirati Therapeutics, Inc.·4

Jun 2, 7:15 PM ET

Stelzer Laurie 4

4 · Mirati Therapeutics, Inc. · Filed Jun 2, 2023

Insider Transaction Report

Form 4
Period: 2023-06-02
Transactions
  • Sale

    Common Stock

    2023-06-02$37.06/sh4,647$172,21880,015 total
Footnotes (1)
  • [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on June 01, 2022.

Documents

3 files